Journal
FERTILITY AND STERILITY
Volume 91, Issue 4, Pages 1529-1532Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2008.08.123
Keywords
Stem cell transplant; ovarian reserve; anti-Mullerian hormone
Categories
Funding
- National Institute of Child Health and Human Development
- National Cancer Institute
- National Institute of Dental and Craniofacial Research, NIH
Ask authors/readers for more resources
In this small pilot study, anti-Mullerian hormone (AMH) levels in women undergoing chemotherapy and hematopoietic stem cell transplantation facilitated earlier identification of impaired ovarian reserve compared with FSH and the resumption of menses. Larger studies are needed to accurately assess the clinical significance of AMH levels in the prediction of long-term reproductive outcomes in reproductive-age transplant patients with our current conditioning regimen. (Fertil Steril (R) 2009;91:1529-32. (C)2009 by American Society for Reproductive Medicine.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available